Armata Pharmaceuticals, Inc. Common Stock ARMP

$2.96 -1.17% at last close
Market Cap$111.21 million
P/E Ratio—
Div Yield—
Volume14.7K
52-Week Range $2.75$16.34

Analyst Ratings

Consensus
Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
Avg. Price Target
$15.00 (+407.6% upside)

Full ARMP forecast & analyst actions →

Key Stats

Today's Range
$2.95 – $3.01
50-Day Range
$2.75 – $6.64
52-Week Range
$2.75 – $16.34
Volume
15K shs
Average Volume
88K shs
Market Cap
$111.21 million
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
0.36%
Days to Cover
1.00

About Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
61
Exchange
XASE
Listed
1994-05-27

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.